Pulmobiotics, backed by Invivo Ventures, receives 1.9m euros to develop ‘living medicine’ for lung cancer

by Invivo Capital

Researchers at Pulmobiotics, a start-up founded in 2020 at the Centre for Genomic Regulation (CRG) in Barcelona backed by Invivo Ventures, have begun work on a ‘living medicine’ to improve the eff...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Eleventh acquisition under Meridia's JV ...

by Meridia Capital Partners

This acquisition signifies Meridia's entry into one of the most esteem...

Photos Stream